Rob Kirby PhD
Rob is a skilled pharmacologist with over 10 years’ experience in ion channel drug discovery. At Metrion Robert leads the team working on a major collaborative drug discovery project with an international pharma company. He also co-ordinates screening activities for CRO work including Metrion’s panel of CiPA cardiac assays.
Prior to his role at Metrion Rob was a Principal Scientist at Xention Ltd (UK) where he lead screening campaigns on behalf of clients for a variety of ion channel targets (Nav1.x, Cav1.x, Cav2.x, Kv1.x, TRPx, Kirx, gIRK, ICrac, HCN and hERG) using automated patch clamp electrophysiology (QPatch, PatchLiner) and fluorescence-based screening platforms (FLIPR, FLEXStation).
Rob obtained his PhD (Sheffield Hallam, UK) investigating a novel pharmacophore for BK potassium channel openers and spent a year at Drexel University (USA) researching the role of GPCR’s in autoimmune disease.
Let’s work together
What are your specific ion channel and assay needs?
If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.